Trilogy Capital’s Invesco S&P 500 Concentrated QVM ETF QVMT Stock Holding History

Trilogy Capital’s Portfolio QVMT Stock Details QVMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-44,705	Closed	-$2.23M	–	343
2024 Q1	$2.23M	Buy	44,705 +17,429	+64%	+$798K	0.13%	129
2023 Q4	$1.21M	Buy	27,276 +9,106	+50%	+$373K	0.07%	141
2023 Q3	$736K	Buy	18,170 +3,648	+25%	+$152K	0.05%	146
2023 Q2	$616K	Buy	14,522 +8,011	+123%	+$317K	0.04%	163
2023 Q1	$261K	Buy	6,511 +1,165	+22%	+$49.1K	0.02%	224
2022 Q4	$219K	Sell	5,346 -233	-4%	-$9.52K	0.02%	238
2022 Q3	$202K	Buy	+5,579	New	+$227K	0.02%	175

Other funds holding QVMT

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CCFM

Clear Creek Financial Management Silverdale, Washington $1.56B AUM 31.02% 1-Year Est. Return

ACM

Armbruster Capital Management Pittsford, New York $671M AUM 24.78% 1-Year Est. Return

DWA

Delta Wealth Advisors Indianapolis, Indiana $140M AUM 16.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Xponance Philadelphia, Pennsylvania $16.3B AUM 44.61% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.3B AUM 18.84% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Trilogy Capital's QVMT Position: Q2 2024 in Review

Trilogy Capital sold out of Invesco S&P 500 Concentrated QVM ETF (QVMT) in Q2 2024, closing a stake of 44,705 shares — an estimated $2.23M sold.

Trilogy Capital first reported a position in QVMT in Q3 2022 and held it in 7 quarters. The position peaked at $2.23M in Q1 2024. 40 funds tracked by Wall St. Rank hold QVMT as of Q2 2024.

Trilogy Capital reported no remaining Invesco S&P 500 Concentrated QVM ETF position as of Q2 2024 after selling out during the quarter.
Trilogy Capital sold 44,705 Invesco S&P 500 Concentrated QVM ETF shares in Q2 2024, an estimated $2.23M.
Trilogy Capital first reported a position in Invesco S&P 500 Concentrated QVM ETF in Q3 2022 and held it in 7 quarters.
Trilogy Capital's Invesco S&P 500 Concentrated QVM ETF position peaked at $2.23M in Q1 2024.
40 funds tracked by Wall St. Rank held Invesco S&P 500 Concentrated QVM ETF as of Q2 2024.

Based on Trilogy Capital's 13F filing for Q2 2024, filed 23 Jul 2024.